NasdaqGS - Delayed Quote USD

Telesis Bio, Inc. (TBIO)

0.3214 +0.0001 (+0.03%)
At close: April 25 at 4:00 PM EDT
0.3351 +0.01 (+4.26%)
After hours: April 25 at 7:47 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
27,509.0000
27,509.0000
27,435.0000
11,043.0000
6,576.0000
Cost of Revenue
10,559.0000
10,559.0000
11,840.0000
6,744.0000
2,951.0000
Gross Profit
16,950.0000
16,950.0000
15,595.0000
4,299.0000
3,625.0000
Operating Expense
52,100.0000
52,100.0000
62,080.0000
39,673.0000
19,986.0000
Operating Income
-35,150.0000
-35,150.0000
-46,485.0000
-35,374.0000
-16,361.0000
Net Non Operating Interest Income Expense
-1,362.0000
-1,362.0000
-1,217.0000
-1,369.0000
-690.0000
Other Income Expense
-11,188.0000
-11,188.0000
-745.0000
-2,201.0000
-954.0000
Pretax Income
-47,700.0000
-47,700.0000
-48,447.0000
-38,944.0000
-18,005.0000
Tax Provision
24.0000
24.0000
24.0000
14.0000
5.0000
Net Income Common Stockholders
-49,024.0000
-49,024.0000
-48,471.0000
-38,958.0000
-18,010.0000
Diluted NI Available to Com Stockholders
-49,024.0000
-49,024.0000
-48,471.0000
-38,958.0000
-18,010.0000
Basic EPS
-1.64
--
-1.65
-2.14
-0.84
Diluted EPS
-1.64
--
-1.65
-2.14
-0.84
Basic Average Shares
29,849.8320
--
29,463.3610
18,222.4950
21,508.1940
Diluted Average Shares
29,849.8320
--
29,463.3610
18,222.4950
21,508.1940
Total Operating Income as Reported
-46,539.0000
-46,539.0000
-46,485.0000
-35,374.0000
-16,361.0000
Total Expenses
62,659.0000
62,659.0000
73,920.0000
46,417.0000
22,937.0000
Net Income from Continuing & Discontinued Operation
-47,724.0000
-47,724.0000
-48,471.0000
-38,958.0000
-18,010.0000
Normalized Income
-38,988.1800
-38,988.1800
-47,902.9900
-37,396.5300
-17,367.6000
Interest Income
1,743.0000
1,743.0000
738.0000
--
--
Interest Expense
3,105.0000
3,105.0000
1,955.0000
1,369.0000
690.0000
Net Interest Income
-1,362.0000
-1,362.0000
-1,217.0000
-1,369.0000
-690.0000
EBIT
-44,595.0000
-44,595.0000
-46,492.0000
-37,575.0000
-17,315.0000
EBITDA
-40,493.0000
-40,493.0000
-43,617.0000
-36,001.0000
-15,858.0000
Reconciled Cost of Revenue
10,559.0000
10,559.0000
11,840.0000
6,744.0000
2,951.0000
Reconciled Depreciation
4,102.0000
4,102.0000
2,875.0000
1,574.0000
1,457.0000
Net Income from Continuing Operation Net Minority Interest
-47,724.0000
-47,724.0000
-48,471.0000
-38,958.0000
-18,010.0000
Total Unusual Items Excluding Goodwill
-11,058.0000
-11,058.0000
-719.0000
-2,139.0000
-880.0000
Total Unusual Items
-11,058.0000
-11,058.0000
-719.0000
-2,139.0000
-880.0000
Normalized EBITDA
-29,435.0000
-29,435.0000
-42,898.0000
-33,862.0000
-14,978.0000
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0003
0.0003
Tax Effect of Unusual Items
-2,322.1800
-2,322.1800
-150.9900
-577.5300
-237.6000
12/31/2020 - 6/18/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NUWE Nuwellis, Inc.
0.2890
+14.64%
 
HSCS Heart Test Laboratories, Inc.
0.0999
-7.41%
 
VTAK Catheter Precision, Inc.
0.5500
-4.35%
 
THMO ThermoGenesis Holdings, Inc.
0.6800
+4.62%
 
MOTS Motus GI Holdings, Inc.
0.0800
+3.90%
 
QTI QT Imaging Holdings, Inc.
0.8100
-7.87%
 
TNON Tenon Medical, Inc.
0.7300
-4.53%
 
AFIB Acutus Medical, Inc.
0.1634
-2.04%
 
LIVN LivaNova PLC
55.10
-1.50%
 
BBLG Bone Biologics Corporation
1.5200
-1.94%